1286902

Brian S. Biesman, MD — FEI 3005765078

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 14, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Nashville, TN (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance